Editas Medicine, Inc. (EDIT)
NASDAQ: EDIT · Real-Time Price · USD
2.230
-0.090 (-3.88%)
At close: Mar 27, 2026, 4:00 PM EDT
2.182
-0.048 (-2.14%)
After-hours: Mar 27, 2026, 7:59 PM EDT
Editas Medicine Market Cap
Editas Medicine has a market cap or net worth of $218.25 million as of March 27, 2026. Its market cap has increased by 91.96% in one year.
Market Cap
218.25M
Enterprise Value
89.71M
1-Year Change
91.96%
Ranking
Category
Stock Price
$2.23
Market Cap Chart
Since February 3, 2016, Editas Medicine's market cap has decreased from $649.70M to $218.25M, a decrease of -66.41%. That is a compound annual growth rate of -10.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 218.30M | 9.10% |
| Dec 31, 2025 | 200.10M | 90.94% |
| Dec 31, 2024 | 104.80M | -87.33% |
| Dec 29, 2023 | 827.40M | 35.66% |
| Dec 30, 2022 | 609.90M | -66.42% |
| Dec 31, 2021 | 1.82B | -58.45% |
| Dec 31, 2020 | 4.37B | 187.69% |
| Dec 31, 2019 | 1.52B | 39.66% |
| Dec 31, 2018 | 1.09B | -15.40% |
| Dec 29, 2017 | 1.29B | 122.48% |
| Dec 30, 2016 | 577.90M | -11.05% |
| Feb 3, 2016 | 649.70M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Voyager Therapeutics | 246.15M |
| Cellectis | 238.62M |
| Camp4 Therapeutics | 236.75M |
| Alector | 233.97M |
| Context Therapeutics | 233.37M |
| Cybin | 232.67M |
| OmniAb | 228.76M |
| Eledon Pharmaceuticals | 224.52M |